Equities

AngioDynamics Inc

AngioDynamics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)6.99
  • Today's Change0.16 / 2.34%
  • Shares traded480.93k
  • 1 Year change+0.14%
  • Beta0.6741
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

  • Revenue in USD (TTM)292.73m
  • Net income in USD-243.03m
  • Incorporated1992
  • Employees748.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Orchestra Biomed Holdings Inc2.65m-57.69m218.25m56.00--4.74--82.45-1.60-1.600.07341.220.02761.0426.3447,267.86-60.19---74.93--92.71---2,179.34--4.21--0.00---21.88---37.91------
Inogen Inc331.52m-52.69m223.42m834.00--1.20--0.6739-2.25-2.2514.097.781.027.818.03397,506.00-16.21-8.23-20.38-9.5344.2244.54-15.89-10.312.34--0.00---16.32-2.49-22.30--26.34--
Utah Medical Products, Inc.44.08m15.26m227.02m169.0015.271.8112.365.154.274.2712.3636.090.33781.9312.23260,816.6011.6912.6912.0513.1958.8061.5734.6230.5126.94--0.0037.05-3.933.640.98341.659.711.86
Trubridge Inc337.67m-58.25m246.86m3.22k--1.43--0.7311-4.09-4.0923.6711.570.8126183.565.84104,900.30-14.401.25-16.501.4149.3150.40-17.721.561.780.80550.505245.063.913.89-387.73--88.71--
Anika Therapeutics Inc164.17m-97.52m248.54m357.00--1.39--1.51-6.64-6.6411.1412.240.58681.475.21459,854.30-34.86-5.41-38.55-5.8762.7060.70-59.40-12.603.78--0.00--6.679.56-456.34--3.11--
LifeMD Inc193.06m-25.61m249.80m207.00------1.29-0.6409-0.64094.85-0.18473.416.2136.89932,652.80-39.18-153.05-240.82-526.9189.6483.66-11.49-45.440.7805-8.831.49--28.1578.9051.27--143.64--
Electromed Inc57.06m6.47m250.38m174.0041.066.0734.224.390.72560.72566.404.911.233.372.42327,931.0013.918.6416.2210.0976.6276.2611.348.065.06--0.000.0013.8311.8262.6721.06-22.23--
Atlantic International Corp313.06m-68.07m259.76m7.00--14.47--0.8297-5.55-5.5512.450.3584.44--10.4844,723,330.00-96.45-71.97-233.48-106.0910.8161.01-21.74-1,471.82---1.640.8328---100.00---37.43------
Zynex Inc193.67m4.82m263.04m1.10k55.787.4728.131.360.14810.14815.911.111.402.577.05176,059.103.4814.584.0617.5280.2079.622.4910.443.154.150.6246--16.5442.01-42.910.37412.19--
Pulmonx Corp79.30m-57.11m268.12m279.00--2.85--3.38-1.47-1.472.042.380.451.247.29284,236.60-32.41-26.27-36.42-28.9774.1671.95-72.01-93.766.77--0.2839--27.9827.98-3.26--20.62--
AngioDynamics, Inc.292.73m-243.03m277.53m748.00--1.42--0.9481-6.04-6.047.254.790.74342.276.55391,344.90-61.72-16.38-74.39-18.7051.7152.95-83.02-30.491.41--0.00---10.282.35-251.53--13.09--
OraSure Technologies, Inc.224.26m11.37m289.43m638.0025.770.680111.821.290.15060.15063.015.710.48622.645.58351,509.402.720.72382.940.821242.2646.945.591.1311.20--0.00040.004.6417.41413.1782.2010.18--
Neuropace Inc76.45m-28.09m289.53m171.00--29.41--3.79-0.9924-0.99242.700.32990.78171.836.69447,087.70-28.72---33.44--73.83---36.74--4.77-4.060.8578--43.72--30.00------
Delcath Systems Inc22.64m-34.12m312.06m76.00--31.91--13.78-1.36-1.360.83430.30590.57140.90946.34297,947.40-86.11-116.57-156.17-243.2181.3171.02-150.70-1,235.371.03-172.600.1892---24.05-9.53-30.60---5.26--
Clearpoint Neuro Inc30.43m-18.15m326.46m107.00--11.26--10.73-0.6912-0.69121.161.050.72421.509.66284,383.20-43.19-34.75-51.20-39.6760.3864.75-59.64-76.913.61--0.00--16.5626.64-34.40--75.30--
Cerus Corp197.91m-19.73m332.43m288.00--6.21--1.68-0.1076-0.10761.080.28821.001.977.88687,194.40-10.01-25.99-15.26-40.6260.5261.90-10.00-35.811.92-1.190.6057---0.806119.6912.37--32.07--
Data as of Nov 25 2024. Currency figures normalised to AngioDynamics Inc's reporting currency: US Dollar USD

Institutional shareholders

40.60%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20243.37m8.29%
Systematic Financial Management LPas of 30 Sep 20242.41m5.93%
The Vanguard Group, Inc.as of 30 Sep 20242.26m5.56%
Millennium Management LLCas of 30 Sep 20242.24m5.50%
Dimensional Fund Advisors LPas of 30 Sep 20241.26m3.11%
Renaissance Technologies LLCas of 30 Sep 20241.06m2.60%
Kent Lake PR LLCas of 30 Sep 20241.00m2.46%
Royce & Associates LPas of 30 Sep 2024986.07k2.43%
Armistice Capital LLCas of 30 Sep 2024962.00k2.37%
Geode Capital Management LLCas of 30 Sep 2024960.77k2.36%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.